Alzheimer’s Drug Market – Global Industry Insights, Market Size Estimation and Growth Forecast, By Drug Class – (Cholinergic, Memantine, Combined Drugs, Others), By Distribution Channels – (Hospital Pharmacy, Retail Pharmacy and Online Stores) & By Regions, 2017 – 2025

Alzheimer's Drug Market Report Code: HC-101-040418 | Category: Healthcare
Format: pdf file iconexcel file iconPPT File Image | No. of Slides: 160 | No. of Figures: 29 | No. of Tables: 20


Alzheimer’s Drug Market - Report Description

Alzheimer's Drug Market Primary Interviews
Alzheimer's Drug Market Primary Interviews Breakdown

The market for Alzheimer's drug has been covered under the scope of this report. Alzheimer's disease is one type of neurodegenerative disease of the brain which leads to loss of cognitive functions and memory. Alzheimer's drug market is expected to witness strong growth during the forecast period. In addition, increase in awareness programs regarding this disease and the rise in the cases of Alzheimer's disease are the major factors contributing to this growth. The global Alzheimer's drugs market has been segmented on the basis of;

  • Drug class
  • Distribution channels, and
  • Regions

It also provides a cross sectional study of the global Alzheimer's drug market across broad regional segments such as North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America under its scope. Across the globe, various Alzheimer vendors which include H Lundbeck A/S, Ono Pharmaceutical and Eisai Co Ltd. among others are continuously focusing on for the development of next-generation Alzheimer's drugs. This in turn is anticipated to has further contributed in the driving the growth of the global Alzheimer's drug market in future. Moreover, some of the latest introduction of Alzheimer's drug which includes passive immunotherapy aducanumab, crenezumab and aducanumab that has the ability to uptake the market during the forecast period. Trends show that last couple of years, Biogen, one of the state's most valuable public biotech company, has invested heavily in Alzheimer's drug research and development. Furthermore, Alzheimer's disease drugs market is expected to experience a potential growth rate because of the high occurrence of Alzheimer's disease followed by the increasing coverage of the Alzheimer's decease by medical treatment. All the above factors are subsequently expected to drive the demand for Alzheimer's drug market worldwide.

Alzheimer's Drug Market Size
Alzheimer's Drug Market Size By Geography
 

Scope of the Report

A complete analysis of market dynamics, which include the market drivers, restraints and opportunities, is included under the scope of the report. Market dynamics for the different drug class and distribution channels have been covered separately, under the purview of the report. Additionally, the country level trend for each region has also been covered under the scope of the report. Thus, this report provides an exhaustive study of the global Alzheimer's drug market and also provides the forecast of the market for the period from 2017 – 2025.


Our Most Rated Consulting Reports


High-level Analyses Covered in the Report

Under the scope of the report on global Alzheimer's drug market, several high-level analyses have been covered. This includes:

  • The product-market trend analysis
  • Product lifecycle analysis
  • Porter's five forces analysis, and
  • Market attractiveness analysis

Key trends analysis discusses the current and upcoming trends of this market. Product lifecycle analysis analyzes the current lifecycle stage of the product in the five wide geographic regions, such as whether the product is approaching maturity in a region or whether it is a new entrant etc. Porter's five forces analysis provides insights on the competitive scenario, with regards to new entrants, substitutes, buyers and suppliers. For providing a detailed insight into the global Alzheimer's drug market, the market attractive analysis has been provided in the report. Market attractiveness analysis details the investment attractiveness, by drug class, by distribution channel and by geography.

Alzheimer's Drug Market Revenue Forecast By Drug Class
Alzheimer's Drug Market Revenue Forecast
 

The Competitive Profiling

The competitive profiling of the key players in the global Alzheimer's drug market and their business segments has been exhaustively covered under the purview of the study. Moreover, key business strategies adopted by the leading players in the market have also been covered under the scope of the report.

 

Leading Companies in the Alzheimer's Drug Market

The global Alzheimer's drug market is characterized by the presence of various large and small vendors across the globe. Some of the major manufactures of Alzheimer's drug includes:

  • H Lundbeck A/S (Denmark)
  • Ono Pharmaceutical (Japan), Eisai Co Ltd. (Japan), and
  • Johnson & Johnson (The U.S) among others.

 

Report Highlights

  • Impeccable insights related to relevant segment of the market.
  • In depth analysis of key trends of the market.
  • In-depth analysis of the competitive landscape and competitor behavior in the market.
  • Major push factors that will influence the growth of the market.
  • Growth potential in different segments of the market till 2025.
  • Key strategies executed by the market leaders to maintain growth in the market.
  • Major restrictive factors of the market.
  • Ways to generate new revenue.
  • Free customization with maximum flexibility limit.

 

The market has been segmented as follows:

Alzheimer's drug market: By Drug Class

  • Cholinergic
  • Memantine
  • Combined Drugs
  • Others

Alzheimer's drug market: By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Stores

Alzheimer's drug market: By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, CIS + Scandinavia and Rest of Europe)
  • Asia-Pacific (China, Japan, Taiwan, South Korea and Rest of Asia-Pacific)
  • Middle East and Africa (Israel, South Africa and Rest of Middle East and Africa)
  • South America (Brazil, Mexico and Rest of South America)

Table of Content

  1. Introduction
    • Study Objective
    • Assumption
    • Acronyms Used
    • Stakeholder Analysis, Mendelow's Matrix
    • Research Scope
    • Market Segmentation
    • Research Limitations
  2. Research Methodology
    • Parameters
    • Data Sources
      • Primary Data Sources
        • Primary Interviews Breakdown, By Geography
        • Primary Interviews Breakdown, By Designation
      • Research Process
        • Primary data collection process
        • Primary data sources
        • Secondary data collection process
        • Secondary data sources
      • Market Size Estimation Technique
        • Top Down Approach
        • Bottom Up Approach
        • Forecasting Technique
  1. Executive Summary
    • Market Size (Value), By Drug Class, 2016 Vs. 2025
    • Market Size (Value), By Distribution Channels, 2016 Vs. 2025
    • Market Size (Value), By Region, 2016 Vs. 2025
  2. Market Overview
    • Market Definition
      • By Drug Class
      • By Distribution Channels
    • Key Trends
    • Product Lifecycle
    • Porter's Five Forces Analysis
    • Market Attractiveness Analysis
  3. Global Alzheimer's Drug Market – Competitive Scenario
    • Production Capacity Share of Key Players
    • Competitive Strategies Adopted by Leading Players
    • List of Growth Activities
      • Organic Growth Activities
      • Inorganic Growth Activities
    • Customer Group Benchmarking
    • Vendor Positioning Matrix
  4. Global Alzheimer's Drug Market – By Drug Class
    • Overview – By Drug Class
    • Key Trends
    • Market Dynamics, By Drug Class
      • Drivers
      • Restraints
      • Opportunities
    • Market Opportunity Heat Map, By Drug Class
    • Cholinergic
    • Memantine
    • Combined Drugs
    • Others
  5. Global Alzheimer's Drug Market – By Distribution Channel
    • Overview – By Distribution Channel
    • Key Trends
    • Market Dynamics, By Distribution Channel
      • Drivers
      • Restraints
      • Opportunities
    • Market Opportunity Heat Map, By Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Stores
  6. North America Alzheimer's Drug Market
    • North America Market: Overview
    • North America Market: By Drug Class
    • North America Market: By Distribution Channel
    • North America Market: By Country
  7. Europe Alzheimer's Drug Market
    • Europe Market: Overview
    • Europe Market: By Drug Class
    • Europe Market: By Distribution Channel
    • Europe Market: By Country
  8. Asia-Pacific Market
    • Asia-Pacific Market: Overview
    • Asia-Pacific Market: By Drug Class
    • Asia-Pacific Market: By Distribution Channel
    • Asia-Pacific Market: By Country
  9. Middle East and Africa Alzheimer's Drug Market
    • Middle East and Africa Market: Overview
    • Middle East and Africa Market: By Drug Class
    • Middle East and Africa Market: By Distribution Channel
    • Middle East and Africa Market: By Country
  10. South America Alzheimer's Drug Market
    • South America Market: Overview
    • South America Market: By Drug Class
    • South America Market: By Distribution Channel
    • South America Market: By Country
  11. Company Profiles
    • Allergan plc.
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview
    • Eisai Co Ltd.
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview
    • Novartis AG
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview
    • Eli Lilly & Co.
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview
    • Johnson & Johnson
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview
    • Ono Pharmaceutical Co Ltd.
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview
    • Daiichi Sankyo Company Ltd.
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview
    • H Lundbeck A/S.
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview
    • Merz Holding GmbH & Co KG
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview
    • GlaxoSmithKline PLC
      • Business Overview
      • Company Description
      • Primary Business Segments
      • SWOT Analysis
      • Strategy Mapping
      • Financial Overview

 

List of Figures

Fig 01 Vendor Positioning Matrix

Fig 02 Market Attractiveness, By Geography (2016)

Fig 03 Market Attractiveness, By Drug Class (2016)

Fig 04 Market Attractiveness, By Distribution Channel (2016)

Fig 05 Production Capacity Share of Key Players (2017)

Fig 06 Global Revenue Forecast (USD Million): By Drug Class (2016 Vs 2025)

Fig 07 Cholinergic - Revenue Forecast

Fig 08 Memantine - Revenue Forecast

Fig 09 Combined Drugs - Revenue Forecast

Fig 10 Others - Revenue Forecast

Fig 11 Global Revenue Forecast (USD Million): By Distribution Channel (2016 Vs 2025)

Fig 12 Hospital Pharmacy - Revenue Forecast

Fig 13 Retail Pharmacy - Revenue Forecast

Fig 14 Online Stores - Revenue Forecast

Fig 15 North America Revenue Forecast (USD Million): By Drug Class

Fig 16 North America Revenue Forecast (USD Million): By Distribution Channel

Fig 17 North America Revenue Forecast (USD Million): By Country

Fig 18 Europe Revenue Forecast (USD Million): By Drug Class

Fig 19 Europe Revenue Forecast (USD Million): By Distribution Channel

Fig 20 Europe Revenue Forecast (USD Million): By Country

Fig 21 Asia-Pacific Revenue Forecast (USD Million): By Drug Class

Fig 22 Asia-Pacific Revenue Forecast (USD Million): By Distribution Channel

Fig 23 Asia-Pacific Revenue Forecast (USD Million): By Country

Fig 24 Middle East and Africa Revenue Forecast (USD Million): By Drug Class

Fig 25 Middle East and Africa Revenue Forecast (USD Million): By Distribution Channel

Fig 26 Middle East and Africa Revenue Forecast (USD Million): By Country

Fig 27 South America Revenue Forecast (USD Million): By Drug Class

Fig 28 South America Revenue Forecast (USD Million): By Distribution Channel

Fig 29 South America Revenue Forecast (USD Million): By Country

 

List of Tables

Table 01 Customer Group Benchmarking

Table 02 Market Opportunity Heat Map, By Type

Table 03 Comparative Analysis of Vendors

Table 04 Market Attractiveness Heat Map, By Drug Class

Table 05 Market Attractiveness Heat Map, By Distribution Channel

Table 06 North America Market, By Drug Class: Revenue Forecast (USD Million)

Table 07 North America Market, By Distribution Channel: Revenue Forecast (USD Million)

Table 08 North America Market, By Country: Revenue Forecast (USD Million)

Table 09 Europe Market, By Drug Class: Revenue Forecast (USD Million)

Table 10 Europe Market, By Distribution Channel: Revenue Forecast (USD Million)

Table 11 Europe Market, By Country: Revenue Forecast (USD Million)

Table 12 Asia-Pacific Market, By Drug Class: Revenue Forecast (USD Million)

Table 13 Asia-Pacific Market, By Distribution Channel: Revenue Forecast (USD Million)

Table 14 Asia-Pacific Market, By Country: Revenue Forecast (USD Million)

Table 15 Middle East and Africa Market, By Drug Class: Revenue Forecast (USD Million)

Table 16 Middle East and Africa Market, By Distribution Channel: Revenue Forecast (USD Million)

Table 17 Middle East and Africa Market, By Country: Revenue Forecast (USD Million)

Table 18 South America Market, By Drug Class: Revenue Forecast (USD Million)

Table 19 South America Market, By Distribution Channel: Revenue Forecast (USD Million)

Table 20 South America Market, By Country: Revenue Forecast (USD Million)

Introduction

Alzheimer's is a type of neurodegenerative disease that effects a part of the brain which helps to control the language, memory and thought process of the person, and in course of time can hamper a person's ability to perform their day to day activities. It is a progressive disease of the brain that leads to loss of memory and various cognitive functions. As Alzheimer's is a progressive disease, its symptoms get gradually worsen over the period of time. Alzheimer's is the most common type of dementia and it accounts for almost 60% - 80% of the dementia cases. Currently, this disease does not have any cure, but can be kept under control through regular treatments with appropriate drugs. However, regular research and development activities are taking place in the field of Alzheimer's drug in order to introduce new drug candidates that have the potentiality of preventing or slowing down the progression of Alzheimer's disease. Some of the latest introduction of Alzheimer's drug includes passive immunotherapies aducanumab, crenezumab and aducanumab that has the ability to uptake the market in the coming seven years. Alzheimer's treatment is a high risk and high reward market. The global Alzheimer's Drug market is anticipated to experience a rapid growth rate throughout the forecast period in terms of revenue (USD Million).

Alzheimer's Drug Market Size and Revenue Share By Geography
Alzheimer's Drug Market Size and Revenue Share
 

Market Dynamics

Rising prevalence of the Alzheimer's diseases across the globe along with increasing awareness about the treatment of Alzheimer's is one of the most important factor anticipated to drive the market of Alzheimer's drug throughout the forecast period from 2017 to 2025. Several neurodegenerative diseases has become increasingly prevalent in developing countries especially among the old age person (age above 65) owing to change in lifestyle and constant tension that leads to brain shrinkage and localized loss of neurons. This in turn is leading to constant support from the government to develop drugs that can control the disease. In addition, the currently available Alzheimer's drugs in the market have reached its maturity and the patents of the leading drugs are either close to expiry or have expired. Thus, the current unmet need is anticipated to create a huge opportunity for various Alzheimer's drug manufacturers in the coming years.

However, high price of these advanced drugs is anticipated to deter its acceptance rate in various developing countries across the globe.

 

Alzheimer's Drug Market Segmentation Overview

For the purpose of providing an In-depth analysis reading the demand of Alzheimer's drug across different geographical regions including North America, Europe, Asia-Pacific, South America and Middle East and Africa, the market has been segmented based on drug class and distribution channel.

Depending on the chemical structure of the medicine, by drug class, the market has been classified into cholinergic, memantine and combined drugs among others.

Based on various channels via which Alzheimer's drug reaches to the end consumers, the market has been classified into hospital pharmacy, retail pharmacy and online stores. In many cases, sales representative of the company also delivers the drugs directly to the end customers. But this has not been considered within our scope of research.

Among the different class of drugs available in the market, the memantine generated the highest revenue in 2016 and is anticipated to maintain its leading position in the coming years. On the other hand, the combined drug is likely to witness the fastest adoption rate during the forecast period owing to its increasing recognition of its efficiency and rising availability across different parts of the world.

 

Regional Outlook

Geographically, North America is projected to dominate the market throughout the forecast period in terms of revenue generation. Higher Alzheimer's disease penetration in this region coupled with wide concentration of global players in this region is the primary factor behind this region's large market share and stable growth rate. On the flip side, owing to rising number of geriatric population, Europe is expected to have immense growth potentiality in the coming eight years.

Get Free Samples for Market Research Reports.
The privacy and security of your shared information are very important to us. Our website is secure and your personal details are safe.

This website is secure and safe. Read our Privacy Policy.

Other Reports